NEW YORK (GenomeWeb News) – Sequenom has settled with its former CEO Harry Stylli who had made an arbitration demand with the company, Sequenom said in its Form 10-Q filed this week. Stylli made the demand in September seeking more than $1.6 million in damages. He alleged the firm fired him without cause and breached his employment agreement by failing to pay him severance benefits.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.